Isotretinoin is a synthetic oral retinoid medication primarily used in dermatology. It is defined as a derivative of vitamin a that modulates epidermal turnover and sebum production. The therapeutic role of Isotretinoin involves the treatment of severe recalcitrant acne and certain dermatologic conditions. Pharmacodynamically it reduces keratinocyte proliferation and normalizes follicular hyperkeratinization. The drug binds to nuclear retinoic acid receptors which leads to transcription of genes involved in skin cell differentiation. Activation of these receptors also suppresses sebaceous gland activity by downregulating lipid synthesis pathways. Metabolism occurs primarily in the liver via cytochrome enzymes resulting in inactive metabolites that are eliminated renally. The sustained plasma concentration achieved through controlled release provides continuous receptor stimulation and therapeutic efficacy.

Isotretinoin is a synthetic retinoid medication used primarily for the treatment of severe recalcitrant acne. Its pharmacological profile encompasses high lipophilicity, extensive metabolism by hepatic cytochrome enzymes, and accumulation in sebaceous glands. Therapeutically, Isotretinoin reduces sebum production, normalizes keratinocyte differentiation, and diminishes inflammatory cytokine release. Mechanism of action involves selective binding to retinoic acid receptors which modulates gene transcription pathways responsible for skin cell growth and inflammation. This receptor activation leads to decreased proliferation of follicular epithelial cells and enhanced apoptosis of acne-forming cells. The resultant reduction in acne lesions is achieved through alteration of sebaceous gland size and activity as well as normalization of follicular hyperkeratosis. Overall, Isotretinoin's pharmacodynamics reflect a potent, long-lasting modification of cutaneous biology that leads to sustained remission of severe acne.

Isotretinoin often causes dry skin that feels tight or flaky. It can lead to chapped lips that require moisturization. Some users experience nosebleeds due to mucosal dryness. The medication may increase sensitivity to sunlight making skin more prone to sunburn. It sometimes elevates liver enzyme levels detectable in blood tests. Joint or muscle discomfort can occur in a minority of patients. Hair thinning or changes in hair texture have been reported.

Isotretinoin often causes dry skin and lips. It can lead to nosebleeds or nasal irritation. Some users experience temporary hair thinning. The medication may increase sensitivity to sunlight. Mood changes such as irritability or anxiety are reported. Blood lipid levels can rise during treatment. Joint aches are a possible side effect. Rarely elevated intracranial pressure has been observed.